Product Information
VENLAFAXINE BES ER 112.5 MG TB is a generic product labeled by Almatica Pharma LLC, priced at $6.1807 per EA under NDC 52427063230. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Jun 29, 2022.
The High Outlier badge above means this manufacturer's average price in the venlafaxine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
112.5 mg/1
Manufacturer
Almatica Pharma LLCNDC
52427063230
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE BESYLATE MONOHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA215429FDA Approved
6/29/2022
On Market Since
6/30/2022
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE BES ER 112.5 MG TB has been published 123 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.1807 per EA |
|---|---|
| All-time high | $6.2179 (Jul 10, 2024) |
| All-time low | $6.1722 (Apr 22, 2026) |
| 52-week high | $6.1928 |
| 52-week low | $6.1722 |
| Median price | $6.1878 |
| Average price | $6.1915 |
| Largest weekly change | -0.2% (Mar 19, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the venlafaxine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE BES ER 112.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE BES ER 112.5 MG TB, manufactured by Almatica Pharma LLC, is $6.1807 per EA (NDC 52427063230), effective Aug 19, 2026.
How has the price of VENLAFAXINE BES ER 112.5 MG TB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE BES ER 112.5 MG TB has held within roughly two percent of its current level. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE BES ER 112.5 MG TB?
Since Apr 17, 2024, the NADAC for VENLAFAXINE BES ER 112.5 MG TB has ranged from a low of $6.1722 (Apr 22, 2026) to a high of $6.2179 (Jul 10, 2024), with a median of $6.1878 per EA.
Are there cheaper alternatives to VENLAFAXINE BES ER 112.5 MG TB?
No other NADAC-published product currently shares the active ingredient and strength of VENLAFAXINE BES ER 112.5 MG TB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VENLAFAXINE BES ER 112.5 MG TB?
VENLAFAXINE BES ER 112.5 MG TB (NDC 52427063230) is labeled by Almatica Pharma LLC, and CMS classifies it as a generic product.